Posted on

World day for safety and health at work

Because there is nothing more important than health and safety

At ROVI, we continue to work on building a positive health and safety culture among our employees. The COVID-19 pandemic has shown the importance of having a sound occupational health and safety system in which all the employees participate. It is the only way for ROVI to remain a space where the well-being of all its workers is assured.

Our strategy to create a culture of awareness of the importance of looking after health and safety at work rests on two basic pillars:

Occupational Risk Prevention (ORP) training

ROVI works with continuing ORP training, which begins when the employee joins the company and continues throughout their professional career with ROVI. This training covers subjects so important as the use of PPE, guidelines for emergencies, ways to avoid injury and rules on accident prevention. The system forms part of an annual training plan, the goal of which is not only to reduce the company’s accident rate, but also to raise employees’ awareness of the importance of protecting health and safety at work.

Near Miss report

To help us improve, at ROVI we have put in place the Near Miss report to report potentially dangerous situations. This document has been distributed by the plants so that any employee can report situations that could lead to an accident directly to the Health and Safety Department. These situations will be studied by the Department and, where necessary, the corrections or improvements necessary to avoid any accident will be made.

This direct communication by the employees is of vital importance. Your contributions help us to strengthen our Occupational Health and Safety System. We are counting on you.

Posted on

New Guidelines in relation to COVID-1

After the revision of the COVID-19 Vigilance and Control Strategy by the Spanish health authorities, we set out below the rules that all ROVI group employees must follow in relation to the prevention of COVID-19, starting Monday, 25 April, 2022:

Compulsory masks

  • Compulsory use of masks indoors in the following situations:
    • At the workstation, when it is not possible to maintain an interpersonal distance equal to or greater than 1.5 metres. If the distance is equal to or greater than 1.5 metres, it will not be necessary to use a mask
    • In all common areas and small enclosed spaces where people may concentrate, such as changing rooms, toilets, canteens and elevators.
  • It will not be compulsory to wear a mask in outdoor spaces.
  • ROVI will continue to provide one surgical mask per person per day to all workers.

Meeting rooms

The limitations on the capacity of meeting rooms will be removed, but it will be compulsory to wear a mask if the interpersonal distance between those present is not equal to or greater than 1.5 metres.

Ventilation

You are reminded that natural ventilation is compulsory for periods of 15 minutes approximately every two hours to favour the renewal of the air in the offices. For example, at 10:00, 12:00, 14:00 and 16:00.

60% in-person presence

We are increasing the proportion of in-person presence at our offices, recovering a percentage of 60%. This means that in-person presence is required for at least three days out of every five.

As an exception, the increase in in-person presence should take place gradually during the coming week. It will be applicable to all departments as of Monday, 2 May, 2022.

As has been the case to date, only the workstations marked with a green sign may be occupied.

Canteen

Use of the canteen will remain the same as at present.

Vulnerable groups

People aged 60 or over, those with weakened immune systems for intrinsic or extrinsic causes, and pregnant women.

People who fall within the above definition must report their situation to the Occupational Hazard Prevention Department in order to arrange an appointment with the occupational health area. If they are found to belong to a vulnerable group, the following measures will be adopted:

  • Workers whose job does not allow teleworking, either totally or partially, will be provided with an FPP2 mask, which they must use throughout the working day, with no exceptions.
  • Workers whose job allows teleworking will work under said system.

Confirmed cases

Workers who are diagnosed as having COVID-19 (through either an antigen test or a PCR) whose doctors have not authorised them to take sick leave (because their symptoms are mild) must observe the following rules:

  • If their job allows teleworking, they must coordinate with their direct superior in order to work under this system for the seven calendar days following the onset of symptoms.
  • If their job does not allow teleworking, infected workers without sick leave must come to work in person, observing the following rules:
    • They must use an FPP2 mask throughout the working day, with no exceptions. The mask will be given to them by their department head (who must ask SYMA for it when he/she becomes aware that there is a positive in her/her team).
    • They must maximise the precautions, limiting all forms of social interaction (meals, breaks, meetings, etc.) to the greatest extent possible.

We remind you that the notification box of ROVI has been disabled and that these infections must be handled in the same way as sick leave for any other reason, i.e. through Human Resources.

All these measures will be reviewed in accordance with the evolution of the instructions of the health authorities applicable to work centres and the evolution of the epidemiological situation.

Posted on

Easter return instructions

According to the latest news, the Spanish health authorities are going to revise their COVID-19 surveillance and control strategy, with the elimination of the compulsory use of masks indoors being planned.

The official publication of this revision is scheduled for 20 April, so we do not yet know the details or the specific effect it will have on workplaces and therefore on ROVI.

In the meantime and until further notice, the rules of conduct we have in force at the moment for the return from the Easter holidays will remain in place: mandatory use of face masks at the workplace and 50% attendance by ROVI Group office staff.

As of 20 April, once the changes are officially published, ROVI will adapt its action protocol to the new legal framework as we have been doing during the pandemic.

Posted on

2 days left to complete the internal mobility survey

Remember that you have until 8 April (inclusive) to complete the internal mobility survey. You can do it through the link below or by filling in the forms that you will find at the entrance of your headquarters or floor.

Help us take a deeper look at ROVI’s impact on the environment by taking this survey on your commute from your place of residence to your workplace in 2020 and 2021.

IMPORTANT: fill in ONLY those workers who do NOT have a company car.

TAKE THE SURVEY HERE

Posted on

Selection of books to read in a day

Do you want to start a new book but don’t have much time to devote to it?

The Roviteca has created the perfect section for you. 18 new books that you can read in less than a day. Titles like:

There is no excuse for not taking a relaxing moment to read one of these titles.

Enter the Roviteca section and enjoy this content and much more.

Posted on

ROVI wins the Salmón Award at the Expansión-Allfund Awards

The Expansión-Allfunds awards brought together the collective investment sector on Tuesday to recognise the best funds and pension plans of 2021. In this thirty-third edition, the newspaper’s readers have awarded Laboratorios Farmacéuticos ROVI with the Salmón Award for the best stock market value of the year, highlighting the exceptional stock market performance experienced last year, with a revaluation of 96%.

The award was collected by Javier López Belmonte, Vice President and CFO of ROVI, who highlighted the great effort made in 2021, both for the manufacture of millions of doses to combat the pandemic and for having achieved approval in Europe of the first drug for schizophrenia based on the ISM platform. “All this effort has been rewarded by the market and we are deeply grateful for it. As you know, at the end of 2021 we will join the Ibex 35, reinforcing the presence of health sector companies in the index at a crucial time for society. The positive performance of the Laboratory’s shares on the stock market since then shows that ROVI is a solid company with a strong and solid future in which investors have confidence,” he said.

In her speech, Ana Isabel Pereda, director of Expansión, stressed the importance of responsible and professional management: “It is in situations of maximum market instability that professional management is most valuable. For this reason, these awards are Expansión’s recognition of the professionals who have to make important investment decisions in such difficult times as the present. Today’s award goes to ROVI in recognition of the immense work carried out by the pharmaceutical sector in the pandemic and, more specifically, for its direct involvement in the manufacture of the Moderna vaccine”.

Posted on

Internal mobility survey

As part of the Greenhouse Gas (GHG) Emissions Inventory, ROVI has decided to analyse the GHG emissions corresponding to the journeys made by each of the company’s employees from their place of residence to their workplace in 2020 and 2021.

Help us to analyse ROVI’s impact on the environment in greater depth by completing the internal mobility survey.

IMPORTANT: fill in ONLY those workers who do NOT have a company car.

Take the survey HERE

You have until 8 April

Posted on

New surveillance and control strategy for COVID-19

In recent days, health authorities have established a new surveillance and control strategy against covid-19 after the acute phase of the pandemic in Spain which implies that:

  • For the general population, the compulsory isolation of both positive cases and those suspected of being positive due to mild symptoms compatible with the infection has been eliminated.
  • The suppression of quarantines are maintained in case of having had close contact with a positive case.
  • In case of presenting symptoms, it is no longer mandatory to perform confirmatory tests (self-diagnostic test or PDIA[1]) or to notify the channels provided by the autonomous communities. Diagnostic tests are restricted to:

o Persons who have any vulnerability[2] criteria.

o People related to vulnerable areas (linked to health centers, social-health centers, day-care centers, prisons, etc.).

o Cases with severe symptoms requiring hospital admission.

o Persons who have been in the last 14 days in a region where a variant of interest or concern is circulating.

This new strategy of the Spanish health authorities implies accepting a certain level of SARS-CoV-2 transmission as long as a sufficiently high level of general vaccination has been achieved to minimize the severity of infections that may occur. For this reason, this new strategy makes it necessary to modify the case management established by ROVI so that, as of next Monday, March 28:

  • Employees will no longer report SARS-CoV2 infections or suspected SARS-CoV2 infections to ROVI.
  • The notificacionescovid19@rovi.es mailbox will be disabled.
  • Persons with symptoms consistent with covid-19 infection should contact their health center and follow their physician’s instructions. In case of sick leave, it will be processed through the usual channels through HR and, as in the case of common illness, they shall no communicate the origin of the illness causing the sick leave.

In addition, we will maintain until further notice the current 50% attendance rate for office personnel, as well as the mandatory use of masks at the workstation and the minimum separation of 1.5 meters between workstations.

As up to now, these measures may be revised if the indications of the health authorities are modified.

Thank you and best regards,

[1]Diagnostic Test for Active SARS-CoV-2 Infection (PCR or rapid test for detection of SARS-CoV-2 antigen, both in nasopharyngeal exudate).

[2] Vulnerability criteria are considered:

– Persons aged 60 years or older.

– Immunosuppressed persons due to intrinsic or extrinsic causes (hematopoietic progenitor transplant recipients or CAR-T, within two years after transplantation/treatment, on immunosuppressive treatment or who have graft-versus-host disease (GVHD), regardless of time since transplantation; solid organ transplant recipients (less than two years or on immunosuppressive treatment for rejection events); primary immunodeficiencies:  combined and B-cell in which absence of vaccine response has been demonstrated; persons who have received in the previous three months (six months in case of rituximab) anti CD20 drugs or belimumab; Down’s syndrome aged over 40 years.

– Pregnant women.

Posted on

ROVI continues its commitment to the integration of people with intellectual disabilities into the workforce

For years, ROVI has been cooperating and collaborating with different associations in the inclusion of people with other abilities in the workplace. Thanks to its work with the Prodis Foundation and Down Granada, ROVI has participated in three projects to accompany people with intellectual disabilities in their process of adapting to their work at the Granada, Pozuelo and Madrid offices.

This adaptation process consists of three main phases:

  1. ROVI identifies the needs of the position and, together with the partnership, searches for a candidate who matches these needs.
  2. The candidate makes contact with his or her functions and tasks in the company accompanied by an employment mediator. This person helps to train the candidate ‘in situ’ and, in addition, provides support to his or her team at ROVI.
  3. As the candidate gains autonomy in the performance of his or her duties, the presence of the mediator decreases until he or she is periodically reviewed to continue his or her work of accompanying the candidate (who is already employed).

Javier Angulo, Director of Human Resources at ROVI, explains: “This accompaniment model provides us with a great deal of security for the companies, as it facilitates the transition to the real world of work for the candidates, and for the work teams it allows us to better understand the needs they may have for their adaptation. These young people show that, with the right training, they are perfectly qualified for employment. In this sense, at ROVI we continue to be committed to facilitating the integration of people with intellectual disabilities into the workplace, as we understand that this is an essential step for the development and autonomy of any person”.

“Thanks to our qualified team of labour mediators and professionals, the Prodis Foundation is able to make the Labour Inclusion Service programme a reality, thus supporting people with intellectual disabilities entering the labour market. This collaboration between the foundation and companies has been vital not only to help in accessing a job, but also to improve their quality of life and their real participation in society,” said María Gil, Director of Communication at the Prodis Foundation.

Posted on

For the second consecutive year, ROVI was carbon neutral in 2021

Laboratorios Farmacéuticos Rovi, S.A. was certified carbon neutral in 2021 for the second year running. Attaining this important milestone was the result of the Group’s Environmental and Social Sustainability Policy and the effort made to reduce the environmental impact of all its activities, within the framework of its “Avoid, reduce, compensate” strategy

Juan López-Belmonte, ROVI’s Chairman and Chief Executive Officer, said: “Our company has significant industrial activity, which makes us especially sensitive to the impact we have on the environment. For this reason, we apply a policy to control and optimise consumption of natural resources at all our plants and make important investments to optimise our efforts to avoid, reduce and offset our emissions”.

ROVI has four medicine production plants in Spain and, for many years, has been applying policies to mitigate the environmental impact of its facilities. Thus, as a company committed to a rational use of energy, ROVI has a specific line of work addressing the optimisation of energy consumption in the course of its activities. Specifically, the actions taken focus on:

  • Avoiding CO2 emissions to the greatest extent possible. For this reason, ROVI purchases renewable energy for the electricity supply required by the production plants, thus minimising the generation of emissions in the course of its operations. Hence, 100% of our production plants completely avoid Scope 2 emissions in the Carbon Footprint relating to energy acquisition.
  • Reduce consumption of key resources: the group checks and reports the water, electricity and gas indicators on a monthly basis and analyses any possible deviations. At each of its manufacturing plants, ROVI sets specific energy-saving targets and has a multidisciplinary team that defines, implements and monitors the actions needed to achieve said targets.
  • Voluntarily compensate for any CO2 emissions that it has not been possible to avoid or reduce during the year. The direct emissions that are offset relate to fuel consumption, such as the natural gas necessary for the industrial boilers or the gas cleaning system, i.e. the Scope 1 emissions when calculating the Carbon Footprint.

For a long time, ROVI been defending and applying its commitment to economic business growth that respects the environment, in line with the United Nations Sustainable Development Goals, more specifically, Goal 12 of the Agenda 2030 “Responsible production and consumption”.